Vanguard Portfolio Management
TECH icon

Vanguard Portfolio Management’s Bio-Techne TECH Stock Holding History

Vanguard Portfolio Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$460M Buy
6,506,360
+26,023
+0.4% +$1.41M 0.02% 751
2026
Q1 		$339M Buy
+6,480,337
New +$389M 0.02% 828

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.43B AUM 18.44% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Vanguard Portfolio Management's TECH Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Bio-Techne (TECH) stake by 0.4% in Q2 2026, buying an estimated $1.41M and bringing the position to 6,506,360 shares worth $460M. The position accounts for 0.02% of the portfolio, ranked #751.

Vanguard Portfolio Management first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 560 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Vanguard Portfolio Management held 6,506,360 shares of Bio-Techne worth $460M as of Q2 2026.
  • Vanguard Portfolio Management bought 26,023 Bio-Techne shares in Q2 2026, an estimated $1.41M.
  • Bio-Techne made up 0.02% of Vanguard Portfolio Management's portfolio in Q2 2026, its #751 holding.
  • Vanguard Portfolio Management first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
  • 560 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.